Thanks, LED. But just pointing out that someone already noticed a difference in language between the last 2 applications...
https://hotcopper.com.au/threads/ann-fda-accepts-mesoblasts-bla-resubmission-for-remestemcel-l.8110020/page-62?post_id=74876192
Just thinking if management had gone for a smaller target after their CRLs but were encouraged enough after the FDA feedback recently to go back to full U18 approval which I am pretty sure was in their initial ODAC application.
Thanks, LED. But just pointing out that someone already noticed...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
0.150(13.0%) |
Mkt cap ! $1.490B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.33 | $1.15 | $25.26M | 19.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 161000 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 50400 | 2 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |